— The Wendy’s Company (NASDAQ: WEN) reported Q4 2019 earnings of $0.08 per share, vs. $0.08 expected.
— Revenues grew 7.4% to $427.2 million, vs. $424.5 million expected.
— Global systemwide sales amounted to $2.7 billion.
— Global systemwide sales growth was 5.9%.
— North America same-restaurant sales growth was 4.3%.
— Company-operated restaurant margin was 14.3%.
— FY2020 global systemwide sales is expected to be approx. $12-12.5 billion.
— FY2020 adjusted EPS is expected to be approx. $0.60-0.62.
— WEN shares fell 0.39% immediately following the announcement.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment